instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'NITROFURANTOIN'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Oral | DrugAdministrationRoute | CC BY-NC | 33733898 | 19,109,856 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | UNK TAPEERED DOSE | DrugDosageText | CC BY-NC | 33733898 | 19,641,818 | 2021 |
What was the outcome of reaction 'Acute kidney injury'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovering | ReactionOutcome | CC BY-NC | 33733898 | 19,323,988 | 2021 |
What was the outcome of reaction 'Glomerulonephritis acute'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovered | ReactionOutcome | CC BY-NC | 33733898 | 19,376,834 | 2021 |
What was the outcome of reaction 'Granuloma'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovering | ReactionOutcome | CC BY-NC | 33733898 | 19,323,988 | 2021 |
What was the outcome of reaction 'Hallucination, visual'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovered | ReactionOutcome | CC BY-NC | 33733898 | 19,376,834 | 2021 |
What was the outcome of reaction 'Medication error'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovered | ReactionOutcome | CC BY-NC | 33733898 | 19,376,834 | 2021 |
What was the outcome of reaction 'Toxicity to various agents'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovered | ReactionOutcome | CC BY-NC | 33733898 | 19,376,834 | 2021 |
What was the outcome of reaction 'Tubulointerstitial nephritis'? | Nitrofurantoin-Associated Acute Granulomatous Interstitial Nephritis.
We report the case of a 71-year-old female who was incidentally found to have nonoliguric acute kidney injury on a routine workup for new-onset visual hallucination. Further history revealed inadvertent usage of nitrofurantoin for 3 months for an ant... | Recovering | ReactionOutcome | CC BY-NC | 33733898 | 19,323,988 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ischaemic'. | Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature.
The COVID-19 pandemic has caused serious health and social concerns worldwide. Although the primary target of SARS-CoV-2 is the respiratory tract, SARS-CoV-2 infection also causes extrapulmonar... | FAVIPIRAVIR, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33735103 | 20,030,261 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature.
The COVID-19 pandemic has caused serious health and social concerns worldwide. Although the primary target of SARS-CoV-2 is the respiratory tract, SARS-CoV-2 infection also causes extrapulmonar... | FAVIPIRAVIR, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33735103 | 20,030,261 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematochezia'. | Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature.
The COVID-19 pandemic has caused serious health and social concerns worldwide. Although the primary target of SARS-CoV-2 is the respiratory tract, SARS-CoV-2 infection also causes extrapulmonar... | FAVIPIRAVIR, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33735103 | 20,030,261 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombosis'. | Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature.
The COVID-19 pandemic has caused serious health and social concerns worldwide. Although the primary target of SARS-CoV-2 is the respiratory tract, SARS-CoV-2 infection also causes extrapulmonar... | FAVIPIRAVIR, HEPARIN SODIUM | DrugsGivenReaction | CC BY-NC | 33735103 | 20,030,261 | 2021-03-18 |
What was the outcome of reaction 'Haematochezia'? | Case Report: Ischemic Enterocolitis Associated with Coronavirus Disease 2019: Two Case Reports and a Review of the Literature.
The COVID-19 pandemic has caused serious health and social concerns worldwide. Although the primary target of SARS-CoV-2 is the respiratory tract, SARS-CoV-2 infection also causes extrapulmonar... | Recovered | ReactionOutcome | CC BY-NC | 33735103 | 20,030,261 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | ORITAVANCIN | DrugsGivenReaction | CC BY | 33735185 | 19,166,314 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | ORITAVANCIN | DrugsGivenReaction | CC BY | 33735185 | 19,166,314 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toe amputation'. | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | ORITAVANCIN | DrugsGivenReaction | CC BY | 33735185 | 19,164,069 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wound infection staphylococcal'. | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | ORITAVANCIN | DrugsGivenReaction | CC BY | 33735185 | 19,166,314 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Wound infection'. | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | ORITAVANCIN | DrugsGivenReaction | CC BY | 33735185 | 19,166,314 | 2021 |
What was the administration route of drug 'ORITAVANCIN'? | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | Intravenous drip | DrugAdministrationRoute | CC BY | 33735185 | 19,166,314 | 2021 |
What was the dosage of drug 'ORITAVANCIN'? | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | 1200 mg (milligrams). | DrugDosage | CC BY | 33735185 | 19,166,314 | 2021 |
What was the outcome of reaction 'Condition aggravated'? | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | Recovering | ReactionOutcome | CC BY | 33735185 | 19,166,314 | 2021 |
What was the outcome of reaction 'Wound infection staphylococcal'? | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | Recovering | ReactionOutcome | CC BY | 33735185 | 19,166,314 | 2021 |
What was the outcome of reaction 'Wound infection'? | Improved economic and clinical outcomes with oritavancin versus a comparator group for treatment of acute bacterial skin and skin structure infections in a community hospital.
Oritavancin is a lipoglycopeptide antibiotic with in vitro bactericidal activity against gram-positive pathogens indicated for use in adults wit... | Recovering | ReactionOutcome | CC BY | 33735185 | 19,166,314 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adverse event'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Agitation'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Fatigue'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal disorder'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Poisoning'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Psychiatric symptom'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM | DrugsGivenReaction | CC BY-NC | 33735464 | 19,101,867 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Seizure'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Somnolence'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Subcutaneous abscess'. | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | LEVETIRACETAM, VALPROIC ACID | DrugsGivenReaction | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
What was the dosage of drug 'LEVETIRACETAM'? | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | MEDIAN DOSE OF 1500 MG (IQR -1500-2000) | DrugDosageText | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
What was the dosage of drug 'VALPROIC ACID'? | First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
This study aimed at estimating the cumulative incidence of antiepileptic drug (AED) treatment failure of first-line monotherapy levetiracetam vs valproic acid in glioma patients with epilepsy.
In this retrospect... | UNKNOWN DOSE | DrugDosageText | CC BY-NC | 33735464 | 21,023,948 | 2021-05 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug effective for unapproved indication'. | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | CANNABIS SATIVA SUBSP. INDICA TOP, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 33736690 | 19,075,520 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | AZATHIOPRINE, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB, PREDNISONE, RITUXIMAB | DrugsGivenReaction | CC BY | 33736690 | 19,101,887 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | CANNABIS SATIVA SUBSP. INDICA TOP, HUMAN IMMUNOGLOBULIN G, PEMBROLIZUMAB, RITUXIMAB | DrugsGivenReaction | CC BY | 33736690 | 19,075,520 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | AZATHIOPRINE, IMMUNE GLOBULIN NOS, PREDNISONE, RITUXIMAB, TACROLIMUS | DrugsGivenReaction | CC BY | 33736690 | 19,107,069 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Toxicity to various agents'. | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | AZATHIOPRINE, PEMBROLIZUMAB, PREDNISONE, TACROLIMUS | DrugsGivenReaction | CC BY | 33736690 | 19,183,453 | 2021-03-19 |
What was the administration route of drug 'HUMAN IMMUNOGLOBULIN G'? | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33736690 | 19,075,520 | 2021-03-19 |
What was the dosage of drug 'AZATHIOPRINE'? | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | UNKNOWN | DrugDosageText | CC BY | 33736690 | 19,183,453 | 2021-03-19 |
What was the dosage of drug 'CANNABIS SATIVA SUBSP. INDICA TOP'? | Steroid-refractory dermatologic and pulmonary toxicity in a patient on rituximab treated with pembrolizumab for progressive urothelial carcinoma: a case report.
BACKGROUND
Increasingly widespread use of programmed cell death protein 1 (PD-1) immune checkpoint inhibitors (ICIs) for treatment of a variety of progressive ... | AT THE TIME OF THIS TREATMENT, HE WAS SMOKING MARIJUANA SEVERAL TIMES PER MONTH | DrugDosageText | CC BY | 33736690 | 19,075,520 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Immune-mediated myocarditis'. | Newly diagnosed cardiovascular disease in patients treated with immune checkpoint inhibitors: a retrospective analysis of patients at an academic tertiary care center.
BACKGROUND
Immune checkpoint inhibitors (ICIs) are a novel class of anticancer agents that have demonstrated clinical response for both solid and hemato... | IPILIMUMAB, NIVOLUMAB | DrugsGivenReaction | CC BY | 33736707 | 19,098,683 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiovascular disorder'. | Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety.
BACKGROUND
World Health Organization recommends countries introducing new drug and short treatment regimen for drug resistant tuberculosis (DR-TB) should develop and implement a system for active p... | AMINOSALICYLIC ACID, BEDAQUILINE, MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33736710 | 19,140,996 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety.
BACKGROUND
World Health Organization recommends countries introducing new drug and short treatment regimen for drug resistant tuberculosis (DR-TB) should develop and implement a system for active p... | AMINOSALICYLIC ACID, BEDAQUILINE, MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33736710 | 19,140,996 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Bedaquiline-containing regimens in patients with pulmonary multidrug-resistant tuberculosis in China: focus on the safety.
BACKGROUND
World Health Organization recommends countries introducing new drug and short treatment regimen for drug resistant tuberculosis (DR-TB) should develop and implement a system for active p... | AMINOSALICYLIC ACID, BEDAQUILINE, MOXIFLOXACIN | DrugsGivenReaction | CC BY | 33736710 | 19,140,996 | 2021-03-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haematochezia'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,197 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,198 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Large intestinal stenosis'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,176 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Large intestine perforation'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,194 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,197 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,194 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Ventricular tachycardia'. | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | GANCICLOVIR | DrugsGivenReaction | CC BY | 33737711 | 19,071,203 | 2021-03-18 |
What was the outcome of reaction 'Haematochezia'? | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | Fatal | ReactionOutcome | CC BY | 33737711 | 19,071,197 | 2021-03-18 |
What was the outcome of reaction 'Hepatic failure'? | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | Fatal | ReactionOutcome | CC BY | 33737711 | 19,071,198 | 2021-03-18 |
What was the outcome of reaction 'Pneumonia'? | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | Fatal | ReactionOutcome | CC BY | 33737711 | 19,071,197 | 2021-03-18 |
What was the outcome of reaction 'Ventricular tachycardia'? | Endoscopic features and clinical outcomes of cytomegalovirus gastroenterocolitis in immunocompetent patients.
We aimed to investigate the endoscopic features and clinical course of CMV gastroenterocolitis in immunocompetent patients. We reviewed the medical records and endoscopic images of 86 immunocompetent patients w... | Fatal | ReactionOutcome | CC BY | 33737711 | 19,071,203 | 2021-03-18 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | Efficacy and safety of immune checkpoint inhibitor monotherapy in elderly patients with non-small cell lung cancer.
The efficacy and safety of immune checkpoint inhibitor (ICI) monotherapy in elderly patients with non-small cell lung cancer (NSCLC) remain unclear, especially in patients older than 80 years. We retrospe... | NIVOLUMAB | DrugsGivenReaction | CC BY | 33738379 | 18,906,061 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Colitis ulcerative'. | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myocarditis'. | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rebound effect'. | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | MESALAMINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
What was the administration route of drug 'PREDNISOLONE'? | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | Oral | DrugAdministrationRoute | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
What was the outcome of reaction 'Colitis ulcerative'? | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | Recovering | ReactionOutcome | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
What was the outcome of reaction 'Myocarditis'? | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | Recovered | ReactionOutcome | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
What was the outcome of reaction 'Rebound effect'? | Mesalazine-induced myopericarditis: a case report.
Mesalazine is a well-established 1st line treatment for inflammatory bowel disease (IBD). Cardiotoxicity following 5-aminosalicyclic-acid therapy remains a rare yet serious complication and can often be challenging to distinguish from myocarditis presenting as an extra... | Recovering | ReactionOutcome | CC BY-NC | 33738396 | 20,009,099 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cough'. | The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.
Timely use of Sacubitril/Valsartan has the potential to significantly improve cardiac function and dramatically r... | BISOPROLOL, CARVEDILOL, ENALAPRIL MALEATE, RAMIPRIL, VALSARTAN | DrugsGivenReaction | CC BY-NC | 33738400 | 20,028,794 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease recurrence'. | The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.
Timely use of Sacubitril/Valsartan has the potential to significantly improve cardiac function and dramatically r... | BISOPROLOL, CARVEDILOL, ENALAPRIL MALEATE, RAMIPRIL, VALSARTAN | DrugsGivenReaction | CC BY-NC | 33738400 | 20,028,794 | 2021-02 |
What was the administration route of drug 'FUROSEMIDE'? | The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.
Timely use of Sacubitril/Valsartan has the potential to significantly improve cardiac function and dramatically r... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33738400 | 20,048,129 | 2021-02 |
What was the administration route of drug 'RAMIPRIL'? | The power of optimal medical therapy using angiotensin receptor-neprilysin inhibitor in acute decompensated heart failure, sparing a critical patient open-heart surgery with a device therapy: a case report.
Timely use of Sacubitril/Valsartan has the potential to significantly improve cardiac function and dramatically r... | Oral | DrugAdministrationRoute | CC BY-NC | 33738400 | 20,028,794 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | DOCETAXEL, DOXORUBICIN, GEMCITABINE, IFOSFAMIDE, MESNA, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Sarcoma'. | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | DOCETAXEL, DOXORUBICIN, GEMCITABINE, IFOSFAMIDE, MESNA, PEGFILGRASTIM | DrugsGivenReaction | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the administration route of drug 'MESNA'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the administration route of drug 'PEGFILGRASTIM'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | Subcutaneous | DrugAdministrationRoute | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the dosage of drug 'DOCETAXEL'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | 70 MILLIGRAM/SQ. METER (ON DAY 8) | DrugDosageText | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the dosage of drug 'DOXORUBICIN'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | 25 MILLIGRAM/SQ. METER, QD (DAY 1-3) | DrugDosageText | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the dosage of drug 'GEMCITABINE'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | 900 MILLIGRAM/SQ. METER (ON DAY 1 AND 8) | DrugDosageText | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the dosage of drug 'IFOSFAMIDE'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | 10 GRAM PER SQUARE METRE (OVER 4 DAYS WITH MENSA) | DrugDosageText | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the dosage of drug 'MESNA'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | 0.5 GRAM PER 100 GRAM (BEFORE IFOSFAMIDE) | DrugDosageText | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the dosage of drug 'PEGFILGRASTIM'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | 6 MILLIGRAM (DAY 5 AS A SUPPORT) | DrugDosageText | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
What was the outcome of reaction 'Death'? | Multimodality imaging of a rare pulmonary artery sessile mass: a case report.
Primary pulmonary artery masses are unusual entities that mimic pulmonary embolism (PE) in clinical presentation and on imaging studies. It is necessary to perform advanced diagnostic exams, such as transesophageal echocardiography (TEE) and ... | Fatal | ReactionOutcome | CC BY-NC | 33738410 | 20,027,090 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute coronary syndrome'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute kidney injury'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase increased'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anaemia'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anxiety'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Arthralgia'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Asthenia'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Back pain'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac disorder'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac failure'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Confusional state'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Constipation'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Depression'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disorientation'. | Cabazitaxel versus abiraterone or enzalutamide in metastatic castration-resistant prostate cancer: post hoc analysis of the CARD study excluding chemohormonal therapy for castrate-naive disease.
BACKGROUND
In the CARD study (NCT02485691), cabazitaxel significantly improved clinical outcomes versus abiraterone or enzalu... | ABIRATERONE ACETATE, ENZALUTAMIDE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC | 33738495 | 17,366,432 | 2021-08-01 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.